Figure 3

Mean Serum Osteocalcin levels at 13 weeks. While PTH treatment (596 ± 138 ng/ml) was significantly different (P < 0.001,*) from OVX (252 ± 57 ng/ml) and SVS (309 ± 74 ng/ml), SVS treatment was not significantly different (NS) from OVX vehicle treated animals after 13 weeks.